BioCatalyst

VIR — Vir Biotechnology, Inc. catalysts

1 verified catalyst event(s) for Vir Biotechnology, Inc. (ticker VIR). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-11-01 — A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11 (month)
in 4mo
ESTIMATED
 READOUT
A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infec
Phase 2 · Viral Hepatitis
 VIR Vir Biotechnology, Inc. Tobevibart, Elebsiran, Bulevirtide ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.